Aspirin and Extended-release Dipyridamole Capsules — Class II drug recall D-1820-2019
Terminated recall by American Health Packaging, reported 2019-08-21, distributed nationwide. Failed Impurities/Degradation Specifications; out of specification result for an unknown impurity in stability
| Recall number | D-1820-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | American Health Packaging, Columbus, OH, United States |
| Recall initiated | 2019-03-01 |
| Classified | 2019-08-15 |
| Reported by FDA | 2019-08-21 |
| Terminated | 2020-09-30 |
| Distributed | Nationwide (US) |
| Quantity | 13,229 cartons |
| Reason classes | specification failure |
| NDC | 60687-0305-32, 60687-0305-33 |
| Lot numbers | 174262, 176469, 177897, 178318, 178436, 179547, 179656 |
| Expiration dates | 2019-03-31, 2019-06-30, 2019-08-31, 2019-09-30, 2019-11-30 |
Product
Aspirin and Extended-release Dipyridamole Capsules, 25 mg/200 mg, 20 capsules per carton (5 blister cards x 4 unit doses), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-305-32; NDC Blister Pack: 60687-305-33
Reason for recall
Failed Impurities/Degradation Specifications; out of specification result for an unknown impurity in stability samples.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1820-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.